Galactose-1-phosphate uridylyltransferase deficiency
Galactose-1-phosphate uridylyltransferase deficiency
Galactose-1-phosphate uridylyltransferase deficiency (GALT deficiency) is a genetic disorder that affects the body's ability to process the simple sugar galactose. It is a type of galactosemia, specifically known as classic galactosemia or Type I galactosemia. This condition is caused by mutations in the GALT gene, which provides instructions for making the enzyme galactose-1-phosphate uridylyltransferase.
Pathophysiology[edit | edit source]
In individuals with GALT deficiency, the enzyme galactose-1-phosphate uridylyltransferase is either absent or not functioning properly. This enzyme is crucial for the conversion of galactose-1-phosphate into UDP-galactose and glucose-1-phosphate. As a result, galactose-1-phosphate accumulates in various tissues, leading to toxic effects and the symptoms associated with the disorder.
Symptoms[edit | edit source]
Symptoms of GALT deficiency typically appear shortly after birth and can include:
- Jaundice
- Hepatomegaly (enlarged liver)
- Vomiting
- Poor feeding
- Failure to thrive
- Lethargy
- Sepsis
- Cataracts
- Developmental delay
Diagnosis[edit | edit source]
Diagnosis of GALT deficiency is usually made through newborn screening programs that test for elevated levels of galactose or galactose-1-phosphate in the blood. Confirmatory testing involves measuring the activity of the galactose-1-phosphate uridylyltransferase enzyme in red blood cells or identifying mutations in the GALT gene through genetic testing.
Treatment[edit | edit source]
The primary treatment for GALT deficiency is a strict galactose-free diet, which involves eliminating lactose and galactose from the diet. This dietary restriction helps prevent the accumulation of toxic substances and alleviates symptoms. Lifelong adherence to the diet is necessary to avoid complications.
Prognosis[edit | edit source]
With early diagnosis and strict dietary management, individuals with GALT deficiency can lead relatively normal lives. However, some may still experience long-term complications such as speech delays, learning disabilities, and ovarian failure in females.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD